$16.15
Price
$993M
Market Cap
—
P/E Ratio
-6.3
Forward P/E
$-3.37
EPS (TTM)
—
Dividend Yield
$352M
Cash
$3M
Total Debt
61M
Shares Out
$5.68
$16.74
52-Week Range
Institutional Ownership of CULLINAN THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for CULLINAN THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2022-Q4 | |||||
| SELL | EXIT | — | — | $12.35 | |
| 2022-Q3 | |||||
| SELL | -72.0% | 429.6K | $6M | $13.42 | |
| 2021-Q4 | |||||
| SELL | -16.3% | 1.5M | $23M | $20.96 | |
| 2021-Q1 | |||||
| BUY | NEW | 1.8M | $72M | $39.68 | |
Insider Trading for CULLINAN THERAPEUTICS INC
6 Months Insider Sentiment
Buy $0
Sell $258K
0
Buys
7
Sells
-258K
Net
1
Grants
Largest
$99K
Ahmed
$45K
Jones
$34K
Sumer
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 31, 2025 | Mary Kay Fenton | Chief Financial Officer | GRANT | 27 | $6.49 | $175 |
| Dec 23, 2025 | Nadim Ahmed | President and CEO | SELL | 9.9K | $10.01 | $99K |
| Dec 19, 2025 | Jennifer Michaelson | Chief Scientific Officer | SELL | 1.3K | $10.01 | $13K |
| Dec 18, 2025 | Jennifer Michaelson | Chief Scientific Officer | SELL | 2.9K | $9.67 | $28K |
| Dec 18, 2025 | Jeffrey Alan Jones | Chief Medical Officer | SELL | 4.6K | $9.67 | $45K |
| Dec 18, 2025 | Jacquelyn L Sumer | Chief Legal Officer | SELL | 3.5K | $9.67 | $34K |
| Dec 15, 2025 | Jennifer Michaelson | Chief Scientific Officer | SELL | 995 | $11.90 | $12K |
| Dec 12, 2025 | Jennifer Michaelson | Chief Scientific Officer | SELL | 2.1K | $12.38 | $27K |